|
|
|
|
|
Management |
|
|
Mark Allegretta, PhD, President and Chief Scientific Officer Dr. Allegretta has over 20 years of experience in biotechnology and academic research and development. He received his PhD from the University of Vermont in 1990, and was a post-doctoral fellow at the Stanford University School of Medicine. Dr. Allegretta is a co-founder of EndoGen and was most recently associated with Connetics Corporation and InterMune Pharmaceuticals.
|
 |
|
|
Ronald D. Guttmann, MD, FRCPC, Executive Vice President, Clinical Development Dr. Guttmann is Emeritus Professor of Medicine and former Director of the McGill University Centre for Clinical Immunobiology and Transplantation. Dr. Guttmann has been active in the biomedical industry and biotechnology investment consulting since 1985.
|
|
|
|
Richard J. Albertini, MD, PhD, Executive Vice President of Research Dr. Albertini is Emeritus Professor of Medicine at the University of Vermont, former Director of the Vermont Cancer Center. He served as President of the Environmental Mutagen Society from 1983-84. Dr. Albertini received the Alexander Hollaender Award of the Environmental Mutagen Society in 1990 and the St. George Medal of the American Cancer Society that same year.
|
 |
|
Copyright © 2008 BioMosaics Inc. | ||
